{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T06:08:38Z","timestamp":1763705318881},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T00:00:00Z","timestamp":1500595200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Innsbruck and Medical University of Innsbruck"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiologe"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s00117-017-0285-0","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T07:35:55Z","timestamp":1500622555000},"page":"840-849","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unerw\u00fcnschte Wirkungen der\u00a0Immuntherapie"],"prefix":"10.1007","volume":"57","author":[{"given":"G.","family":"Widmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. A.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Plaickner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Jaschke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,21]]},"reference":[{"key":"285_CR1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1753465816636557","volume":"10","author":"O Abdel-Rahman","year":"2016","unstructured":"Abdel-Rahman O, Fouad M (2016) Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a\u00a0meta-analysis. Ther Adv Respir Dis 10:183\u2013193","journal-title":"Ther Adv Respir Dis"},{"key":"285_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1530\/EJE-14-0845","volume":"172","author":"F Albarel","year":"2015","unstructured":"Albarel F, Gaudy C, Castinetti F et al (2015) Long-term follow-up of ipilimumab-induced hypophysitis, a\u00a0common adverse event of the anti-CTLA-4 antibody in melanoma. Eur J Endocrinol 172:195\u2013204","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"285_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s40618-015-0301-z","volume":"38","author":"PB Araujo","year":"2015","unstructured":"Araujo PB, Coelho MC, Arruda M et al (2015) Ipilimumab-induced hypophysitis: review of the literature. J\u00a0Endocrinol Invest 38(11):1159\u20131166. doi: 10.1007\/s40618-015-0301-z","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"285_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00261-015-0560-3","volume":"41","author":"AR Barina","year":"2016","unstructured":"Barina AR, Bashir MR, Howard BA et al (2016) Isolated recto-sigmoid colitis: a\u00a0new imaging pattern of ipilimumab-associated colitis. Abdom Radiol (NY) 41(2):207\u2013214. doi: 10.1007\/s00261-015-0560-3","journal-title":"Abdom Radiol (NY)"},{"key":"285_CR5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3348\/kjr.2017.18.1.42","volume":"18","author":"M Braschi-Amirfarzan","year":"2017","unstructured":"Braschi-Amirfarzan M, Tirumani SH, Hodi FS Jr. et al (2017) Immune-checkpoint inhibitors in the era of precision medicine: What radiologists should know. Korean J Radiol 18:42\u201353","journal-title":"Korean J Radiol"},{"key":"285_CR6","doi-asserted-by":"publisher","first-page":"W992","DOI":"10.2214\/ajr.10.6198","volume":"197","author":"Y Bronstein","year":"2011","unstructured":"Bronstein Y, Ng CS, Hwu P et al (2011) Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy. AJR Am J Roentgenol 197:W992\u2013W1000. doi: 10.2214\/ajr.10.6198","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"285_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/annrheumdis-2016-209595","volume":"76","author":"LC Cappelli","year":"2017","unstructured":"Cappelli LC, Gutierrez AK, Baer AN et\u00a0al (2017) Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab. Ann Rheum Dis 76(1):43\u201350. doi: 10.1136\/annrheumdis-2016-209595","journal-title":"Ann Rheum Dis"},{"key":"285_CR8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/CJI.0000000000000060","volume":"38","author":"MM Chan","year":"2015","unstructured":"Chan MM, Kefford RF, Carlino M et al (2015) Arthritis and tenosynovitis associated with the anti-PD1 antibody pembrolizumab in metastatic melanoma. J\u00a0Immunother 38:37\u201339","journal-title":"J Immunother"},{"key":"285_CR9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jgh.12888","volume":"30","author":"R Cheng","year":"2015","unstructured":"Cheng R, Cooper A, Kench J et al (2015) Ipilimumab-induced toxicities and the gastroenterologist. J Gastroenterol Hepatol 30:657\u2013666","journal-title":"J. Gastroenterol. Hepatol."},{"key":"285_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.clineuro.2014.06.011","volume":"125","author":"Y Chodakiewitz","year":"2014","unstructured":"Chodakiewitz Y, Brown S, Boxerman JL et\u00a0al (2014) Ipilimumab treatment associated pituitary hypophysitis: clinical presentation and imaging diagnosis. Clin Neurol Neurosurg 125:125\u2013130. doi: 10.1016\/j.clineuro.2014.06.011","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"285_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11894-017-0540-6","volume":"19","author":"P Cramer","year":"2017","unstructured":"Cramer P, Bresalier RS (2017) Gastrointestinal and hepatic complications of immune checkpoint inhibitors. Curr Gastroenterol Rep 19(1):3. doi: 10.1007\/s11894-017-0540-6","journal-title":"Curr Gastroenterol Rep"},{"key":"285_CR12","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.33549\/physiolres.933525","volume":"65","author":"R Demlova","year":"2016","unstructured":"Demlova R, Valik D, Obermannova R et al (2016) The safety of therapeutic monoclonal antibodies: implications for cancer therapy including immuno-checkpoint inhibitors. Physiol Res 65:S455\u2013S462","journal-title":"Physiol Res"},{"key":"285_CR13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40644-016-0066-4","volume":"16","author":"S Diederich","year":"2016","unstructured":"Diederich S (2016) Chest CT for suspected pulmonary complications of oncologic therapies: How I review and report. Cancer Imaging 16:7","journal-title":"Cancer Imaging"},{"issue":"11","key":"285_CR14","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1210\/jc.2014-2306","volume":"99","author":"AT Faje","year":"2014","unstructured":"Faje AT, Sullivan R, Lawrence D et al (2014) Ipilimumab-induced hypophysitis: a\u00a0detailed longitudinal analysis in a\u00a0large cohort of patients with metastatic melanoma. J\u00a0Clin Endocrinol Metab 99(11):4078\u20134085. doi: 10.1210\/jc.2014-2306","journal-title":"J Clin Endocrinol Metab"},{"key":"285_CR15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/CCO.0000000000000358","volume":"29","author":"L Heinzerling","year":"2017","unstructured":"Heinzerling L, Goldinger SM (2017) A review of serious adverse effects under treatment with checkpoint inhibitors. Curr Opin Oncol 29:136\u2013144","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"285_CR16","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10637-013-9939-6","volume":"31","author":"KW Kim","year":"2013","unstructured":"Kim KW, Ramaiya NH, Krajewski KM et\u00a0al (2013) Ipilimumab associated hepatitis: imaging and clinicopathologic findings. Invest New Drugs 31(4):1071\u20131077. doi: 10.1007\/s10637-013-9939-6","journal-title":"Invest New Drugs"},{"issue":"5","key":"285_CR17","doi-asserted-by":"publisher","first-page":"W468","DOI":"10.2214\/ajr.12.9751","volume":"200","author":"KW Kim","year":"2013","unstructured":"Kim KW, Ramaiya NH, Krajewski KM et al (2013) Ipilimumab-associated colitis: CT findings. AJR Am J Roentgenol 200(5):W468\u2013W474. doi: 10.2214\/ajr.12.9751","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"285_CR18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2217\/imt-2016-0029","volume":"8","author":"HR Kourie","year":"2016","unstructured":"Kourie HR, Klastersky J (2016) Immune checkpoint inhibitors side effects and management. Immunotherapy 8(7):799\u2013807. doi: 10.2217\/imt-2016-0029","journal-title":"Immunotherapy"},{"key":"285_CR19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2017.00049","volume":"8","author":"V Kumar","year":"2017","unstructured":"Kumar V, Chaudhary N, Garg M et\u00a0al (2017) Current diagnosis and management of immune related adverse events (irAes) induced by immune checkpoint inhibitor therapy. Front Pharmacol 8:49","journal-title":"Front Pharmacol"},{"issue":"2","key":"285_CR20","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1148\/rg.352140121","volume":"35","author":"JJ Kwak","year":"2015","unstructured":"Kwak JJ, Tirumani SH, Van Den Abbeele AD et al (2015) Cancer immunotherapy: imaging assessment of novel treatment response patterns and immune-related adverse events. Radiographics 35(2):424\u2013437. doi: 10.1148\/rg.352140121","journal-title":"Radiographics"},{"issue":"10","key":"285_CR21","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/phar.1643","volume":"35","author":"NM La-Beck","year":"2015","unstructured":"La-Beck NM, Jean GW, Huynh C et al (2015) Immune checkpoint inhibitors: new insights and current place in cancer therapy. Pharmacotherapy 35(10):963\u2013976. doi: 10.1002\/phar.1643","journal-title":"Pharmacotherapy"},{"issue":"13","key":"285_CR22","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1056\/nejmc1509660","volume":"373","author":"J Larkin","year":"2015","unstructured":"Larkin J, Hodi FS, Wolchok JD (2015) Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N\u00a0Engl J Med 373(13):1270\u20131271. doi: 10.1056\/nejmc1509660","journal-title":"N Engl J Med"},{"issue":"1","key":"285_CR23","doi-asserted-by":"publisher","first-page":"e5747","DOI":"10.1097\/md.0000000000005747","volume":"96","author":"CS Lu","year":"2017","unstructured":"Lu CS, Liu JH (2017) Pneumonitis in cancer patients receiving anti-PD-1 and radiotherapies: three case reports. Medicine (Baltimore) 96(1):e5747. doi: 10.1097\/md.0000000000005747","journal-title":"Medicine (Baltimore)"},{"key":"285_CR24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s12020-014-0199-9","volume":"47","author":"J Marlier","year":"2014","unstructured":"Marlier J, Cocquyt V, Brochez L et al (2014) Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports. Endocrine 47:878\u2013883","journal-title":"Endocrine"},{"issue":"24","key":"285_CR25","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1158\/1078-0432.ccr-16-1320","volume":"22","author":"M Nishino","year":"2016","unstructured":"Nishino M, Ramaiya NH, Awad MM et al (2016) PD-1 inhibitor-related pneumonitis in advanced cancer patients: radiographic patterns and clinical course. Clin Cancer Res 22(24):6051\u20136060. doi: 10.1158\/1078-0432.ccr-16-1320","journal-title":"Clin Cancer Res"},{"key":"285_CR26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ctrv.2016.02.001","volume":"44","author":"L Spain","year":"2016","unstructured":"Spain L, Diem S, Larkin J (2016) Management of toxicities of immune checkpoint inhibitors. Cancer Treat Rev 44:51\u201360","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"285_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/art.40043","volume":"69","author":"ME Suarez-Almazor","year":"2017","unstructured":"Suarez-Almazor ME, Kim ST, Abdel-Wahab N et al (2017) Review: immune-related adverse events with use of checkpoint inhibitors for immunotherapy of cancer. Arthritis Rheumatol 69(4):687\u2013699. doi: 10.1002\/art.40043","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"285_CR28","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1158\/2326-6066.cir-15-0102","volume":"3","author":"SH Tirumani","year":"2015","unstructured":"Tirumani SH, Ramaiya NH, Keraliya A et al (2015) Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with ipilimumab. Cancer Immunol Res 3(10):1185\u20131192. doi: 10.1158\/2326-6066.cir-15-0102","journal-title":"Cancer Immunol Res"},{"key":"285_CR29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12885-015-1074-7","volume":"15","author":"O Venditti","year":"2015","unstructured":"Venditti O, De Lisi D, Caricato M et al (2015) Ipilimumab and immune-mediated adverse events: a\u00a0case report of anti-CTLA4 induced ileitis. BMC Cancer 15:87","journal-title":"BMC Cancer"},{"key":"285_CR30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.alit.2016.04.009","volume":"65","author":"S Watanabe","year":"2016","unstructured":"Watanabe S, Kimura H, Takato H et\u00a0al (2016) Severe pneumonitis after nivolumab treatment in a\u00a0patient with melanoma. Allergol Int 65:487\u2013489","journal-title":"Allergol Int"}],"container-title":["Der Radiologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00117-017-0285-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-017-0285-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00117-017-0285-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T03:22:14Z","timestamp":1602559334000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00117-017-0285-0"}},"subtitle":["Klinik, radiologische und nuklearmedizinische Befunde"],"short-title":[],"issued":{"date-parts":[[2017,7,21]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["285"],"URL":"https:\/\/doi.org\/10.1007\/s00117-017-0285-0","relation":{},"ISSN":["0033-832X","1432-2102"],"issn-type":[{"value":"0033-832X","type":"print"},{"value":"1432-2102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,21]]}}}